| ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non–Small Cell Lung Cancer JF Gainor, AM Varghese, SHI Ou, S Kabraji, MM Awad, R Katayama, ... Clinical cancer research 19 (15), 4273-4281, 2013 | 635 | 2013 |
| Pocket medicine: the Massachusetts General Hospital handbook of internal medicine MS Sabatine Lippincott Williams & Wilkins, 2013 | 86 | 2013 |
| STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer Q Wang, JS Bergholz, L Ding, Z Lin, SK Kabraji, ME Hughes, X He, S Xie, ... Nature Communications 13 (1), 3022, 2022 | 81 | 2022 |
| Drug resistance in HER2-positive breast cancer brain metastases: blame the barrier or the brain? S Kabraji, J Ni, NU Lin, S Xie, EP Winer, JJ Zhao Clinical Cancer Research 24 (8), 1795-1804, 2018 | 81 | 2018 |
| Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma CM McKee, D Xu, Y Cao, S Kabraji, D Allen, V Kersemans, J Beech, ... The Journal of clinical investigation 122 (11), 4025-4036, 2012 | 56 | 2012 |
| JARID1B enables transit between distinct states of the stem-like cell population in oral cancers ND Facompre, KM Harmeyer, X Sole, S Kabraji, Z Belden, V Sahu, ... Cancer research 76 (18), 5538-5549, 2016 | 52 | 2016 |
| CPEB1 regulates β‐catenin mRNA translation and cell migration in astrocytes KJ Jones, E Korb, MA Kundel, AR Kochanek, S Kabraji, M McEvoy, ... Glia 56 (13), 1401-1413, 2008 | 45 | 2008 |
| Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases S Kabraji, J Ni, S Sammons, T Li, AED Van Swearingen, Y Wang, ... Clinical Cancer Research 29 (1), 174-182, 2023 | 42 | 2023 |
| Temporal and spatial topography of cell proliferation in cancer G Gaglia, S Kabraji, D Rammos, Y Dai, A Verma, S Wang, CE Mills, ... Nature cell biology 24 (3), 316-326, 2022 | 35 | 2022 |
| Integrating immunotherapy and targeted therapy in cancer treatment: mechanistic insights and clinical implications JS Bergholz, Q Wang, S Kabraji, JJ Zhao Clinical Cancer Research 26 (21), 5557-5566, 2020 | 30 | 2020 |
| Improving orthotopic mouse models of patient-derived breast cancer brain metastases by a modified intracarotid injection method Z Liu, Y Wang, S Kabraji, S Xie, P Pan, Z Liu, J Ni, JJ Zhao Scientific reports 9 (1), 622, 2019 | 29 | 2019 |
| AKT1low quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer S Kabraji, X Solé, Y Huang, C Bango, M Bowden, A Bardia, D Sgroi, ... Breast Cancer Research 19, 1-12, 2017 | 26 | 2017 |
| AKT1low Quiescent Cancer Cells Promote Solid Tumor Growth CP Alves, I Dey-Guha, S Kabraji, AC Yeh, NP Talele, X Solé, ... Molecular cancer therapeutics 17 (1), 254-263, 2018 | 21 | 2018 |
| PI3Kβ controls immune evasion in PTEN-deficient breast tumours JS Bergholz, Q Wang, Q Wang, M Ramseier, S Prakadan, W Wang, ... Nature 617 (7959), 139-146, 2023 | 15 | 2023 |
| p16INK4A-deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastases J Ni, S Kabraji, S Xie, Y Wang, P Pan, X He, Z Liu, JP Leone, HW Long, ... Nature Communications 13 (1), 1473, 2022 | 14 | 2022 |
| Abstract PD4-05: Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases (BCBM) S Kabraji, J Ni, S Sammons, AED Van Swearingen, Y Wang, ... Cancer Research 82 (4_Supplement), PD4-05-PD4-05, 2022 | 7 | 2022 |
| Preclinical evaluation of neratinib plus T-DM1 in orthotopic PDX models of HER2-positive breast cancer brain metastases J Ni, Y Wang, I Diala, S Kabraji, R Freedman, N Lin, J Zhao Cancer Research 79 (13_Supplement), 4832-4832, 2019 | 4 | 2019 |
| Temporal and spatial topography of cell proliferation in cancer G Gaglia, S Kabraji, D Argyropoulou, Y Dai, S Wang, J Bergholz, S Coy, ... BioRxiv, 2021.05. 16.443704, 2021 | 3 | 2021 |
| Abstract HER2-05: HER2-05 Comprehensive genomic characterization of HER2-low breast cancer P Tarantino, HV Gupta, ME Hughes, JL Files, S Strauss, G Kirkner, ... Cancer Research 83 (5_Supplement), HER2-05-HER2-05, 2023 | 2 | 2023 |
| THER-12. Preclinical evaluation of neratinib plus T-DM1 in orthotopic PDX models of HER2-positive breast cancer brain metastases J Ni, Y Wang, I Diala, S Kabraji, R Freedman, N Lin, J Zhao Neuro-oncology Advances 1 (Suppl 1), i13, 2019 | 2 | 2019 |
Justin GainorDirector, Center for Thoracic Cancers, Massachusetts General HospitalVerified email at partners.org
